Your browser doesn't support javascript.
loading
Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement.
Mociková, Heidi; Malikova, Hana; Holesta, Michal; Elturki, Abdulfattah; Campr, Vit; Kozak, Tomas.
Afiliación
  • Mociková H; Department of Internal Medicine and Hematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Malikova H; Department of Radiology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Holesta M; Department of Radiology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Elturki A; Department of Medical Oncology and Hematology, Misurata Cancer Center, Misurata, Libyan Arab Jamahiriya.
  • Campr V; Institute of Pathology and Molecular Medicine, University Hospital Motol, Prague, Czech Republic.
  • Kozak T; Department of Internal Medicine and Hematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Am J Case Rep ; 21: e921657, 2020 Mar 14.
Article en En | MEDLINE | ID: mdl-32170052
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Sistema Nervioso Central / Progresión de la Enfermedad / Brentuximab Vedotina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Am J Case Rep Año: 2020 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias del Sistema Nervioso Central / Progresión de la Enfermedad / Brentuximab Vedotina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: Am J Case Rep Año: 2020 Tipo del documento: Article País de afiliación: República Checa